These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5183 related articles for article (PubMed ID: 3756941)
1. Dose-response relationship to dacarbazine demonstrated in a patient with malignant melanoma. Hoelzer KL; Harrison BR; Luedke DW; Mahanta B Cancer Treat Rep; 1986 Oct; 70(10):1211-2. PubMed ID: 3756941 [TBL] [Abstract][Full Text] [Related]
2. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine. Melichar B; Voboril Z; Lojík M; Krajina A Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711 [TBL] [Abstract][Full Text] [Related]
4. Sequential treatment of melanoma patients who progressed on interleukin-2 and dacarbazine by alpha-interferon and dacarbazine--a preliminary report. Merimsky O; Inbar M; Shiloni E; Ron I; Chaitchik S Mol Biother; 1990 Dec; 2(4):208-10. PubMed ID: 2288720 [TBL] [Abstract][Full Text] [Related]
5. [Regional intra-arterial chemotherapy with Dacarbazine in isolated liver metastases of a malignant melanoma]. Böckers M; Keller E; Bork K Dtsch Med Wochenschr; 1988 Jan; 113(1):20-1. PubMed ID: 3335193 [TBL] [Abstract][Full Text] [Related]
6. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma. Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091 [TBL] [Abstract][Full Text] [Related]
7. [A case of liver metastasis from anorectal malignant melanoma on hemodialysis treated by chemotherapy]. Tezuka K; Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S; Yanagawa N Gan To Kagaku Ryoho; 2007 Oct; 34(10):1709-12. PubMed ID: 17940397 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results. Rudolf Z; Plesnicar S Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959 [TBL] [Abstract][Full Text] [Related]
9. Intraarterial chemotherapy of malignant melanoma metastatic to the liver. Melichar B; Dvorák J; Jandík P; Tousková M; Solichová D; Megancová J; Voboril Z Hepatogastroenterology; 2001; 48(42):1711-5. PubMed ID: 11813606 [TBL] [Abstract][Full Text] [Related]
10. Single-dose dacarbazine and dactinomycin in advanced malignant melanoma. Hochster H; Levin M; Speyer J; Dunleavy S; Harris M; Roses D; Golomb F; Muggia F Cancer Treat Rep; 1985 Jan; 69(1):39-42. PubMed ID: 3967259 [TBL] [Abstract][Full Text] [Related]
11. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma]. Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103 [TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of metastatic melanoma confined to the liver. Papachristou DN; Fortner JJ Int Surg; 1983; 68(2):145-8. PubMed ID: 6885293 [TBL] [Abstract][Full Text] [Related]
13. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785 [TBL] [Abstract][Full Text] [Related]
14. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule. Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898 [TBL] [Abstract][Full Text] [Related]
16. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver. Ueda H; Hamagami H; Tanaka H; Kida Y; Ichinose M Oncol Rep; 2005 Dec; 14(6):1543-6. PubMed ID: 16273253 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. Bedikian AY; Millward M; Pehamberger H; Conry R; Gore M; Trefzer U; Pavlick AC; DeConti R; Hersh EM; Hersey P; Kirkwood JM; Haluska FG; J Clin Oncol; 2006 Oct; 24(29):4738-45. PubMed ID: 16966688 [TBL] [Abstract][Full Text] [Related]
18. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
19. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study. Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK; Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859 [TBL] [Abstract][Full Text] [Related]
20. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma]. Célérier P; Dreno B; Bureau B; Litoux P Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]